This is because TB-500 research suggests that it can be applied in daily doses starting from 0.5mcg/kg of body weight up to considerably higher doses for 10-14 days [23, 24]
Patients inject the medication into the abdomen, thigh, or upper arm, rotating injection sites to minimize local reactions
Results The pathogenesis of CKD in patients with T2D likely involves many contributors besides hyperglycemia, such as hypertension, obesity, insulin resistance and glomerular atherosclerosis, exerting kidney damage through metabolic, fibrotic, inflammatory, and hemodynamic mechanisms
A realistic framework for what to expect outside a trial setting: For many people, even 1015% weight loss produces substantial improvements in blood pressure, blood sugar, sleep quality, joint pain, and overall metabolic health
The medication may cause persistent nausea, vomiting, abdominal pain, or fatigue that interferes with daily life